USPTO serial 78136332
ORPHAN
Reviewed by CopyMark Law Group
Reg. 3654760Status 710
- Filing date
- Status date
- Registration date
- Jul 14, 2009
- Examiner
- SHARPER JR, SAM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ORPHAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Swedish Orphan International AB
Stockholm, SE
Swedish Orphan International AB
Stockholm, SE
Swedish Orphan International AB
Stockholm, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael W. Garvey
MICHAEL W GARVEY PEARNE & GORDON LLP1801 E 9TH ST STE 1200CLEVELAND, OH 44114-3108UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; medicines for human use, namely, medicines for the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; and pharmaceutical preparations and medicine for human use for treatment of pain | SECTION 8 - CANCELLED | Apr 15, 2002 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Swedish Orphan International AB
- Other trademarks owned by Swedish Orphan International AB
- Other trademarks owned by Swedish Orphan International AB
- Other trademarks in Class 005
- Similar marks named ORPHAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 14, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 28, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 23, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 19, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 19, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 19, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 19, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 19, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 19, 2009 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 16, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 3, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 3, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 3, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 3, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 3, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 3, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2009 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 27, 2008 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 27, 2008 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 27, 2007 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 20, 2007 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 20, 2007 | ALIE | ASSIGNED TO LIE | — |
| Aug 9, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 12, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 16, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 1, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 8, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2004 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 22, 2004 | CFIT | CASE FILE IN TICRS | — |
| Sep 15, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 5, 2003 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 14, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2003 | PAPER RECEIVED | — | |
| Oct 10, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2002 | DOCK | ASSIGNED TO EXAMINER | — |